Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2024-05-12 Investor Presentation
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation titled 'INVESTOR PRESENTATION Q4FY24 & FY24' from Neuland Laboratories Limited, dated May 12, 2024. It includes comprehensive financial highlights for Q4FY24 and FY24, management commentary, business strategy, segment revenue breakdowns, key operating metrics, and company overview. The content is typical of an investor presentation focusing on financial results, business strategy, and market position. There is no indication that this is an official annual report (10-K), earnings release (ER), or regulatory filing. The document is not a brief announcement or a certification letter but a full presentation intended for investors and analysts. Therefore, the appropriate classification is Investor Presentation (IP).
2024-05-12 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the publication of financial results for the quarter and year ended March 31, 2024. It includes an extract of consolidated audited financial results with key financial figures such as total income, net profit before and after tax, earnings per share, and other financial metrics. The document mentions that the financial results have been reviewed by the Audit Committee and approved by the Board of Directors on May 10, 2024. It also states that the full detailed financial results are filed with the stock exchanges and available on their websites and the company's website. The document is essentially a public announcement of the financial results, including an extract of the audited results, but it does not contain the full detailed financial statements or comprehensive analysis typical of a full Annual Report (10-K) or Interim Report (IR). The document is longer than 5,000 characters and contains substantive financial data, so it is not merely a report publication announcement (RPA). Given the nature of the content—quarterly and annual financial results with audit committee review and board approval, published as per regulatory requirements—this fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights. Therefore, the appropriate classification is Earnings Release (ER). FY 2024
2024-05-11 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates by a shareholder and the request for issuance of a 'Letter of Confirmation' in lieu of physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an announcement about a shareholder's share certificate loss and does not contain financial data, management discussion, voting results, or any report publication. It is not a report or financial statement but a regulatory notification related to shareholding records. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-10 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation addressed to stock exchanges and investors, explicitly titled "Investors/Analysts Presentation" and referencing financial results for the quarter and year ended March 31, 2024. It includes comprehensive financial highlights, management commentary, business strategy, segment revenue, operating metrics, and company overview. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or a brief summary. It is not a full annual report (10-K) but rather a presentation aimed at investors summarizing quarterly and annual financial performance and strategic outlook. Therefore, it fits the definition of an Investor Presentation (IP).
2024-05-10 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter and full year ended March 31, 2024. It includes key financial highlights such as revenue, EBITDA, PAT, and EPS, but does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). It also mentions an upcoming earnings call where management will discuss the results. The document is relatively short (4931 characters) and serves as an initial announcement of quarterly and annual financial results, which aligns with the definition of an Earnings Release (ER). There is no indication that this is a full report or detailed management discussion, nor is it a simple announcement of a report publication. Therefore, the appropriate classification is Earnings Release (ER). FY 2024
2024-05-10 English
Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from Neuland Laboratories Limited regarding the outcome of a Board Meeting held on May 10, 2024. It includes approval of audited financial results for the year ended March 31, 2024, both standalone and consolidated, as per Indian Accounting Standards. The document also contains the Statutory Auditors' Report with an unmodified opinion on these financial statements. Additionally, it mentions the recommendation of a final dividend, the scheduling of the 40th Annual General Meeting, and the re-appointment of the Statutory Auditors. The presence of comprehensive audited financial results, auditor's detailed opinion, and financial data for the full fiscal year indicates this is the official Annual Report or equivalent annual financial results filing. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2024
2024-05-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.